Ambien

Known as: ambien [brand name] 
brand name of zolpidem, a drug used to treat insomnia
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2016
02419952016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Zolpidem (Ambien, 1) is an imidazo[1,2-a]pyridine-3-acetamide and an approved drug for the treatment of insomnia. As medicinal… (More)
  • figure 1
  • table 1
Is this relevant?
2015
2015
BACKGROUND Sleep issues such as insomnia affect over 50 million Americans and can lead to serious health problems, including… (More)
Is this relevant?
2013
2013
Sleep affects declarative memory for emotional stimuli differently than it affects declarative memory for nonemotional stimuli… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
Review
2012
Review
2012
The current research examines correlates of Ambien misuse among adolescents. Given the recent popularity of prescription drug… (More)
Is this relevant?
2007
2007
The imidazopyridine zolpidem (Ambien) is one of the most commonly prescribed sleep aids in the United States (Rush, 1998… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
1999
1999
This report describes two cases of acute zolpidem overdose. The decedent in the first case was a 36-year-old female found dead in… (More)
Is this relevant?
1997
1997
OBJECTIVE To determine in healthy volunteers (men and women; 18 to 40 years old) the potential cross-reactivity of Ambien… (More)
Is this relevant?
Review
1997
Review
1997
BACKGROUND In 1993, the nonbenzodiazepine sedative-hypnotic zolpidem tartrate (Ambien) was approved for use in the US. Zolpidem… (More)
Is this relevant?
1996
1996
Zolpidem (Ambien) is an imidazopyridine hypnotic recently introduced in the USA. We report a case of a fatal overdose of Ambien… (More)
Is this relevant?
1995
1995
Zolpidem (Ambien), a relatively new nonbenzodiazepine sedative-hypnotic, was involved in the death of a 39-year-old obese male… (More)
Is this relevant?